Valsartan and Hydrochlorothiazide

Product NDC
63629-7282
11-digit product format
636297282
Labeler code
63629
Product ID
63629-7282_5cc6eb0a-e2be-4260-ba6d-63149e41eeb2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Valsartan and Hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA203145
Marketing category
ANDA
Marketing start
2013-04-19
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Active strength
12.5; 320 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Valsartan and Hydrochlorothiazide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYDROCHLOROTHIAZIDE12.5 mg/1
VALSARTAN320 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii0J48LPH2TH, 80M03YXJ7I
Rxcui200284, 349353, 636042

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
692a3434-fece-49c6-9b7d-ed7aefc52b50Product name320260317
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
1199f4b7-b537-466c-9a1c-cb09131e9f8bProduct name120251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6fProduct name320251027
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
265792b3-b999-c010-7364-a7db20b9d4d9Product name520250515
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
e7dfdaab-7cf9-4f89-804c-eff5108d94d1Product name920250305
b6abae2f-ee27-47bc-b150-54dc8d969483Product name220250221
52311e76-a520-4bd2-9d5b-e0b6d6f44519Product name220231208
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
162cbc9d-ecc3-72ba-af9f-c76e2756ef54Product name320221207
9b303cd4-3186-2454-5706-3137e8b2dfd2Product name420221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0eaProduct name120200505
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
8b67f333-47d1-8464-7ce4-406d3dbb295fProduct name720190618
89a57420-ab44-5323-14f9-595159145f9bProduct name220190612
c27b049d-3258-48cf-ebe5-08c236ae78e2Product name320190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058Product name420180613
15b375b1-89c7-9594-80df-5a8c8864aee0Product name320180108
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3dProduct name220170719
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502Product name220150320
ea069444-e874-4c28-833f-d2f52734ef4dProduct name120150206
041df61b-f8b6-48a6-7b67-411e1412678bProduct name120140508
0ad8bdca-888e-00da-648b-6a4de854a167Product name120140508
433a3439-b8f3-d13a-d2c8-9b221d628d60Product name120140508
59212689-39e5-a976-6d21-882d76d8079aProduct name120140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212Product name120140508
78637fb0-95c8-441f-e4b4-db1274b6f956Product name120140508
df89bd47-2db4-d593-ab37-d11953fd5536Product name120140508
f151007d-265d-9fbe-857d-1d44f1cb76baProduct name120140508
f5231d08-c52b-a5a0-ba93-675895c292beProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63629-7282-12020-10-16C16284748780-19d75b9d0-6f79-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS, safely and effectively. See full prescribing information for VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS. VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1998
63629-7282-22020-10-16C16284748780-19d75b9d0-6f79-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS, safely and effectively. See full prescribing information for VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS. VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1998
63629-7282-12020-01-31C16284748780-19d75b9d0-6f79-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS, safely and effectively. See full prescribing information for VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS. VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1998
63629-7282-22020-01-31C16284748780-19d75b9d0-6f79-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS, safely and effectively. See full prescribing information for VALSARTAN and HYDROCHLOROTHIAZIDE TABLETS. VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-7282-1Valsartan and Hydrochlorothiazide30 in 1 BOTTLETABLET, FILM COATED301015
63629-7282-2Valsartan and Hydrochlorothiazide90 in 1 BOTTLETABLET, FILM COATED901015

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-7282VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1015Current NDC, Legacy NDC, 2 package rows20231212_167f49f0-2d39-49a2-9f9e-1359a7c7ba3d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200284HCTZ 12.5 MG / valsartan 80 MG Oral TabletPSN167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
349353valsartan 160 MG / hydroCHLOROthiazide 25 MG Oral TabletPSN167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
636042valsartan 320 MG / hydroCHLOROthiazide 12.5 MG Oral TabletPSN167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
636042hydrochlorothiazide 12.5 MG / valsartan 320 MG Oral TabletSCD167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
200284hydrochlorothiazide 12.5 MG / valsartan 80 MG Oral TabletSCD167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
349353hydrochlorothiazide 25 MG / valsartan 160 MG Oral TabletSCD167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
636042HCTZ 12.5 MG / valsartan 320 MG Oral TabletSY167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
200284HCTZ 12.5 MG / valsartan 80 MG Oral TabletSY167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015
349353HCTZ 25 MG / valsartan 160 MG Oral TabletSY167f49f0-2d39-49a2-9f9e-1359a7c7ba3d1015

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
63629-7282-16362972820130 TABLET, FILM COATED in 1 BOTTLE (63629-7282-1) 2017-05-160000-00-00NoNoCurrent
63629-7282-26362972820290 TABLET, FILM COATED in 1 BOTTLE (63629-7282-2) 2017-05-160000-00-00NoNoCurrent